Christopher Zergebel

Christopher Zergebel joined ITBMed in June of 2023 and brings over 25 years of experience in drug development in both Project Management and Clinical Operations in all phases of drug development.  Prior to joining ITBMed, he served as Aileron Therapeutics’ Vice President of Program Management and Clinical Operations providing strategic leadership to teams and moving development efforts forward globally within the oncology space. Prior to Aileron, Chris spent more than 15 years in roles of increasing responsibility at Taiho Oncology, Inc., most recently as Vice President, R&D Services, overseeing Clinical Project Management, Clinical Operations, Data Management, Medical Writing, and Clinical Supplies through all phases of Clinical Development and through regulatory approvals. He also served as Vice President, Project Management at Taiho Oncology, responsible for global project management of all oncology development programs, as well as consistent project planning and management across all Global Project Teams and all phases of clinical and post-marketing drug development. Earlier in his career, Chris also held project management roles at PRA International,  Organon, Inc., and Quintiles. He received his Bachelor of Arts in Biology from Boston University.